Search results
Annie F. Luetkemeyer (born April 13, 1972, Baltimore, Maryland, U.S.) is an American physician and researcher who is Professor of Medicine and Infectious Diseases at the University of California, San Francisco.
Clinical Professor. HIV, Infectious Disease, and Global Medicine, Infectious Diseases. Interests: HIV therapeutic strategies, COVID-19 treatment and prevention, Sexually Transmitted Infections, DoxyPEP, Viral hepatitis, Hepatitis C, Hepatitis Elimination. Clinical Trials:
Long-term in vitro exposure of Treponema pallidum to sub-bactericidal doxycycline did not induce resistance: Implications for doxy-PEP and syphilis. bioRxiv. 2024 Jun 27. Tantalo LC, Luetkemeyer A, P Lieberman NA, Nunley BE, Avendaño C, Greninger AL, Celum C, Giacani L. PMID: 38979216; PMCID: PMC11230427.
It’s a rare day when Annie Luetkemeyer, MD, puts in fewer than 12 hours at Zuckerberg San Francisco General Hospital. A UCSF physician-researcher, Luetkemeyer previously helped advance effective HIV drugs and a cure for hepatitis C.
Annie Luetkemeyer. Professor. School of Medicine. annie.luetkemeyer@ucsf.edu. +1 415 502-5753. Publications. Community-Based Point-of-Diagnosis Hepatitis C Treatment for Marginalized Populations: A Nonrandomized Controlled Trial. JAMA network open. Morris MD, McDonell C, Luetkemeyer AF, Thawley R, McKinney J, Price JC.
Comparison of Quantiferon to Conventional Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV Positive Subjects. Mentored Scientist Award, Spring 2005. Award Mentor: Diane.
Jul 13, 2023 · If taken within 72 hours of condomless sex, the common antibiotic doxycycline drastically reduces the risk of gonorrhea, syphilis and chlamydia among transwomen and gay, bisexual and other men who have sex with men, a recent study shows. Annie Luetkemeyer, MD. Professor of Infectious Diseases.
